Replies to post #20609 on NorthWest Biotherapeutics Inc (NWBO)

[Evaluate]

the PR does state:

.... with six months of the existing exercise period changed to a restricted period when the warrant cannot be exercised, followed by a two and a half year exercise period, and with a warrant exercise price of $5.15 per share.

So why is there a 6 month period during which warrant cannot be exercised?
Could it be that NWBO believes stock price might be able to rise substantially during next 6 months, provided the warrant is not exercised during this period?

You next post mentions stock price of $3 ... perhaps this should be "on the way to $10+".

[longusa]

bluesky, warrant coverage of financings are pretty standard stuff for pre-approval / cash-flow-negative small cap biotechs. I see nothing out of the ordinary. Yes, you or I can't get a LEAP option for free; but neither can we provide 11m - at least I can't ... yet:)